These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2142274

  • 1. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
    Soussy CJ, Le Van Thoi J, Cluzel M, Derlot E, Kitzis MD.
    Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [In vitro antibacterial activity of rokitamycin, a new macrolide antibiotic. Results of a multicenter study].
    Soussy CJ, Le Van Thoi J, Meyran M, Joly B, Derlot E, Morel C.
    Pathol Biol (Paris); 1990 May; 38(5):407-12. PubMed ID: 2195450
    [Abstract] [Full Text] [Related]

  • 4. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
    Soussy CJ, Le Van Thoi J, Morel C, Acar JF, Thabaut A, Fleurette J, Vallée E, Dabernat H, Chanal M, Drugeon H.
    Pathol Biol (Paris); 1990 May; 38(5):390-6. PubMed ID: 2195448
    [Abstract] [Full Text] [Related]

  • 5. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
    Soussy CJ, Thabaut A, Bismuth R, Morel C, Berthelot G, Chanal M, Derlot E.
    Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study].
    Soussy CJ, Deforges L, Le Van Thoi J, Thabaut A, Meyran M, Chanal M, Cluzel M, Brun Y, Coulet M, Fleurette J.
    Pathol Biol (Paris); 1984 May; 32(5):326-30. PubMed ID: 6330645
    [Abstract] [Full Text] [Related]

  • 8. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin, against hospital bacteria and regression curve].
    Soussy CJ, Cluzel M, Derlot E, Kitzis MD, Meyran M.
    Pathol Biol (Paris); 1994 May; 42(5):385-92. PubMed ID: 7824301
    [Abstract] [Full Text] [Related]

  • 9. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve].
    Soussy CJ, Duval J, Chanal M, Sirot D, Bergogne-Bérézin E, Joly-Guillou ML, Malbruny B, Morel C.
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743
    [Abstract] [Full Text] [Related]

  • 10. [In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study].
    Soussy CJ, Morel C, Kitzis MD, Meyran M, Brun Y, Joly-Guillou ML, Dabernat H, Chanal M, Courtieu AL, Derlot E.
    Pathol Biol (Paris); 1991 May; 39(5):403-9. PubMed ID: 1881670
    [Abstract] [Full Text] [Related]

  • 11. Disk diffusion sensitivity testing and antibacterial activity of azithromycin.
    Davila D, Tambić T, Djokić S, Kolacny-Babić L.
    Arzneimittelforschung; 1992 Feb; 42(2):156-9. PubMed ID: 1319164
    [Abstract] [Full Text] [Related]

  • 12. [In vitro activity of imipenem against hospital bacteria].
    Soussy CJ, Duval J.
    Presse Med; 1990 Apr 04; 19(13):583-7. PubMed ID: 2139936
    [Abstract] [Full Text] [Related]

  • 13. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].
    Soussy CJ, Le Van Thoi J, Duval J, Morel C, Malbruny B, Acar JF, Kitzis MD, Mounier M, Denis F, Courvalin P.
    Pathol Biol (Paris); 1986 May 04; 34(5):390-8. PubMed ID: 3534711
    [Abstract] [Full Text] [Related]

  • 14. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
    Soussy CJ, Otterbein G, Le Van Thoi J, Thabaut A, Meyran M, Courtieu AL, Reynaud A, Dabernat H, Lareng MB, Chanal M.
    Pathol Biol (Paris); 1985 Jun 04; 33(5 Pt 2):487-92. PubMed ID: 3911142
    [Abstract] [Full Text] [Related]

  • 15. [In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve].
    Soussy CJ, Cluzel M, Derlot E, Exmelin L, Kitzis MD, Dabernat H, Le Noc P, Muller-Serieys C, Reverdy ME, Scheftel JM, Thabaut A.
    Pathol Biol (Paris); 1996 Apr 04; 44(4):241-8. PubMed ID: 8763585
    [Abstract] [Full Text] [Related]

  • 16. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L, Devos J, Romond C, Bryskier A.
    Pathol Biol (Paris); 1986 May 04; 34(5):440-4. PubMed ID: 3534717
    [Abstract] [Full Text] [Related]

  • 17. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S, Ianniello F, Leone S, Esposito S.
    J Antimicrob Chemother; 2003 Nov 04; 52(5):869-72. PubMed ID: 14519672
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of ertapenem: review of recent studies.
    Wexler HM.
    J Antimicrob Chemother; 2004 Jun 04; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [Abstract] [Full Text] [Related]

  • 19. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
    Soussy CJ, Deforges L, Le Van Thoi J, Chanal M, Sirot D, Acar JF, Kitzis MD, Thabaut A, Meyran M, Dabernat H.
    Pathol Biol (Paris); 1985 Jun 04; 33(5 Pt 2):469-72. PubMed ID: 2868442
    [Abstract] [Full Text] [Related]

  • 20. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC, Danziger LH, Rodvold KA.
    Clin Pharm; 1992 Feb 04; 11(2):137-52. PubMed ID: 1312921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.